Clinical Trial

Transcranial Pulse Stimulation for Alzheimer's Disease

Study acronym: TPS
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
TPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hypothesized that TPS can modulate neuronal activity, enhance synaptic plasticity, and reduce neuroinflammation. It is a relatively new application in neurological disease treatment and is still under intense investigation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-20; most recent amendment 2025-09-15.
Trial Details
NCT Number NCT07143734
Lead Sponsor Chinese University of Hong Kong
Collaborators: Asia Pacific Institute of Healthy ageing, Associated medical supplies company limited, Dongguan University of Technology, SuZhou Engin Bio-medical Electronics.Co.Ltd.
Conditions Alzheimer Dementia (AD)
Enrollment 40 participants
Start Date 2025-07-21
Primary Completion 2026-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-16